Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-08-2020 | Cholangiocarcinoma | Letter to the Editor

[⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

Authors: Jieling Zheng, Shaobo Yao

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2020

Excerpt

Dear Sir, …

Chen HJ, Pang YZ, Wu JX, Zhao L, Hao B, Wu J, et al. Comparison of [⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020. https://link.springer.com/article/10.1007/s00259-020-04769-z. Accessed 30 Mar 2020.

Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, et al. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases. 2019;7(14):1732–52.CrossRef

Glasbrenner B, Ardan M, Boeck W, Preclik G, Möller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy. 1999;31(9):712–7.CrossRef

Jailwala J, Fogel EL, Sherman S, Gottlieb K, Flueckiger J, Bucksot LG, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc. 2000;51:383–90.CrossRef

Nishiyama Y, Yamamoto Y, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, et al. Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun. 2007;28(12):914–9.CrossRef

Lewis HL, Rahnemai-Azar AA, Dillhoff M, Schmidt CR, Pawlik TM. Current management of perihilar cholangiocarcinoma and future perspectives. Chirurgia (Bucur). 2017;112(3):193–207.

Luo YP, Pan QQ, Zhang W. IgG4-related disease revealed by ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2019;46(12):2625–6.

Luo YP, Pan QQ, Zhang W, Li F. Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in ⁶⁸Ga-FAPI PET/CT. Clin Nucl Med. 2020;45(4):310–1.CrossRef

Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. ⁶⁸Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801–5.CrossRef

10.

Choi EK, Yoo IR, Kim SH, JH O, Choi WH, Na SJ, et al. The clinical value of dual-time point ¹⁸F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease. Clin Nucl Med. 2013;38(3):106–11.CrossRef

Title: [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer
Authors: Jieling Zheng
Shaobo Yao
Publication date: 01-08-2020
Publisher: Springer Berlin Heidelberg
Keywords: Cholangiocarcinoma
Cholangiocarcinoma
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-020-04847-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

[⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

Correction to: Nuclear medicine services after COVID-19: gearing up back to normality

Adrian Dawkins (Ed). Ultrasound Q&A: Review for the Boards

Preservation of brain metabolism in recently diagnosed Parkinson’s impulse control disorders

Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma

Impact of the COVID-19 crisis on imaging in oncological trials

Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT—potential insights